These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7794130)
21. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities. Lugnier C; Gauthier C; Le Bec A; Soustre H Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of rolipram on partially purified phosphodiesterase 4 from rat brains. Ohsawa F; Yamauchi M; Nagaso H; Murakami S; Baba J; Sawa A Jpn J Pharmacol; 1998 Jun; 77(2):147-54. PubMed ID: 9681571 [TBL] [Abstract][Full Text] [Related]
23. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties. Minneman KP J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605 [TBL] [Abstract][Full Text] [Related]
24. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810 [TBL] [Abstract][Full Text] [Related]
25. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Yoshimura T; Kurita C; Nagao T; Usami E; Nakao T; Watanabe S; Kobayashi J; Yamazaki F; Tanaka H; Nagai H Gen Pharmacol; 1997 Oct; 29(4):633-8. PubMed ID: 9352314 [TBL] [Abstract][Full Text] [Related]
26. Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line. Zurbonsen K; Michel A; Vittet D; Bonnet PA; Chevillard C Biochem Pharmacol; 1997 Apr; 53(8):1141-7. PubMed ID: 9175719 [TBL] [Abstract][Full Text] [Related]
27. Bemoradan--a novel inhibitor of the rolipram-insensitive cyclic AMP phosphodiesterase from canine heart tissue. Moore JB; Combs DW; Tobia AJ Biochem Pharmacol; 1991 Jul; 42(3):679-83. PubMed ID: 1650219 [TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue. Giembycz MA; Barnes PJ Biochem Pharmacol; 1991 Jul; 42(3):663-77. PubMed ID: 1650218 [TBL] [Abstract][Full Text] [Related]
30. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse. Cherry JA; Thompson BE; Pho V Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656 [TBL] [Abstract][Full Text] [Related]
32. Selective inhibitors of specific phosphodiesterases in intact adipocytes. Manganiello V; Degerman E; Elks M Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789 [No Abstract] [Full Text] [Related]
33. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058 [TBL] [Abstract][Full Text] [Related]
34. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast. Wilson M; Sullivan M; Brown N; Houslay MD Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):407-15. PubMed ID: 7528009 [TBL] [Abstract][Full Text] [Related]
35. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum. Qiu Y; Kraft P; Lombardi E; Clancy J J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172 [TBL] [Abstract][Full Text] [Related]
36. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue. Price B; Pyne NJ; Houslay MD Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712 [TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of a low-Km 3':5'-cyclic adenosine phosphodiesterase from post-meiotic male mouse germ cells. Giorgi M; Piscitelli D; Rossi P; Geremia R Biochim Biophys Acta; 1992 May; 1121(1-2):178-82. PubMed ID: 1318079 [TBL] [Abstract][Full Text] [Related]
38. Partial purification of adenosine 3',5'-cyclic monophosphate phosphodiesterases from rat pancreas in the presence of excess protease inhibitors. Terai M; Furihata C; Matsushima T; Sugimura T Arch Biochem Biophys; 1976 Oct; 176(2):621-9. PubMed ID: 185966 [No Abstract] [Full Text] [Related]
39. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Schwabe U; Miyake M; Ohga Y; Daly JW Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926 [No Abstract] [Full Text] [Related]
40. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase. Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]